The Latest Cardiac and Vascular News
ENGLEWOOD, Colo., Sept. 3, 2020 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced order growth for July and August 2020. Aggregate orders in July and August were 83% above the prior […]
– Revenue increased 87% year over year to $19.3 million – Orders increased 37% – Net income of $3.0 million; Diluted EPS $0.09 – Adjusted EBITDA increased 69% to $4.8 million ENGLEWOOD, Colo., July 28, 2020 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of […]
ENGLEWOOD, Colo., July 14, 2020 /PRNewswire/ — Zynex, Inc. (“Zynex”) (Nasdaq: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today the pricing of its previously announced underwritten public offering of an aggregate of 2,500,000 shares of its […]
ENGLEWOOD, Colo., July 9, 2020 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced orders and an increased revenue estimate for Q2 and the full-year 2020. Orders in the second quarter […]
ENGLEWOOD, Colo., May 18, 2020 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced it has introduced a full catalog of physical therapy products for distribution through its US sales […]
– Revenue increased 66% year over year to $15.2 million – Orders increased 126% – Net income of $2.9 million; Diluted EPS $0.09 – Adjusted EBITDA increased 23% to $3.0 million ENGLEWOOD, Colo., April 28, 2020 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of […]
ENGLEWOOD, Colo., April 7, 2020 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced orders and an increased revenue estimate for Q1 and the full year 2020. Orders in the first quarter […]
ENGLEWOOD, Colo., Feb. 27, 2020 /PRNewswire/ — 2019 Full Year Revenue increased 42% year over year to $45.5 million Net income $9.5 million; Diluted EPS $0.28 2019 Revenue, net income and Adjusted EBITDA are the highest in Company history Adjusted EBITDA increased 11% to $12.1M 2019 Fourth Quarter Revenue increased 52% year over year to $14.2 million […]
ENGLEWOOD, Colo., Feb. 25, 2020 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced the U.S. Food and Drug Administration (“FDA”) granted 510(k) clearance for sale in the U.S. for […]
ENGLEWOOD, Colo., Jan. 7, 2020 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it has signed an addendum to its corporate headquarters building lease expanding the footprint to 86,000 square […]
